These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 23460813

  • 1. Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus.
    Geller R, Andino R, Frydman J.
    PLoS One; 2013; 8(2):e56762. PubMed ID: 23460813
    [Abstract] [Full Text] [Related]

  • 2. Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter.
    Noton SL, Nagendra K, Dunn EF, Mawhorter ME, Yu Q, Fearns R.
    J Virol; 2015 Aug; 89(15):7786-98. PubMed ID: 25995255
    [Abstract] [Full Text] [Related]

  • 3. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM, Wang Z, Kemble G, Duke G.
    PLoS One; 2015 Aug; 10(12):e0144648. PubMed ID: 26659560
    [Abstract] [Full Text] [Related]

  • 4. Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex.
    Cox RM, Toots M, Yoon JJ, Sourimant J, Ludeke B, Fearns R, Bourque E, Patti J, Lee E, Vernachio J, Plemper RK.
    J Biol Chem; 2018 Oct 26; 293(43):16761-16777. PubMed ID: 30206124
    [Abstract] [Full Text] [Related]

  • 5. Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery.
    Heylen E, Neyts J, Jochmans D.
    Biochem Pharmacol; 2017 Mar 01; 127():1-12. PubMed ID: 27659812
    [Abstract] [Full Text] [Related]

  • 6. Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase.
    Liuzzi M, Mason SW, Cartier M, Lawetz C, McCollum RS, Dansereau N, Bolger G, Lapeyre N, Gaudette Y, Lagacé L, Massariol MJ, Dô F, Whitehead P, Lamarre L, Scouten E, Bordeleau J, Landry S, Rancourt J, Fazal G, Simoneau B.
    J Virol; 2005 Oct 01; 79(20):13105-15. PubMed ID: 16189012
    [Abstract] [Full Text] [Related]

  • 7. Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells.
    Harcourt JL, McDonald M, Svoboda P, Pohl J, Tatti K, Haynes LM.
    BMC Res Notes; 2016 Jan 05; 9():11. PubMed ID: 26732674
    [Abstract] [Full Text] [Related]

  • 8. The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin.
    Kim YI, Pareek R, Murphy R, Harrison L, Farrell E, Cook R, DeVincenzo J.
    Influenza Other Respir Viruses; 2017 Nov 05; 11(6):525-530. PubMed ID: 28990339
    [Abstract] [Full Text] [Related]

  • 9. Discovery of 4'-chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection.
    Wang G, Deval J, Hong J, Dyatkina N, Prhavc M, Taylor J, Fung A, Jin Z, Stevens SK, Serebryany V, Liu J, Zhang Q, Tam Y, Chanda SM, Smith DB, Symons JA, Blatt LM, Beigelman L.
    J Med Chem; 2015 Feb 26; 58(4):1862-78. PubMed ID: 25667954
    [Abstract] [Full Text] [Related]

  • 10. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication In Vitro.
    Jorquera PA, Mathew C, Pickens J, Williams C, Luczo JM, Tamir S, Ghildyal R, Tripp RA.
    J Virol; 2019 Feb 15; 93(4):. PubMed ID: 30541831
    [Abstract] [Full Text] [Related]

  • 11. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
    Perron M, Stray K, Kinkade A, Theodore D, Lee G, Eisenberg E, Sangi M, Gilbert BE, Jordan R, Piedra PA, Toms GL, Mackman R, Cihlar T.
    Antimicrob Agents Chemother; 2015 Dec 14; 60(3):1264-73. PubMed ID: 26666922
    [Abstract] [Full Text] [Related]

  • 12. Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection.
    Ivanciuc T, Sbrana E, Ansar M, Bazhanov N, Szabo C, Casola A, Garofalo RP.
    Am J Respir Cell Mol Biol; 2016 Nov 14; 55(5):684-696. PubMed ID: 27314446
    [Abstract] [Full Text] [Related]

  • 13. Antiviral activity of ginseng extract against respiratory syncytial virus infection.
    Lee JS, Ko EJ, Hwang HS, Lee YN, Kwon YM, Kim MC, Kang SM.
    Int J Mol Med; 2014 Jul 14; 34(1):183-90. PubMed ID: 24756136
    [Abstract] [Full Text] [Related]

  • 14. The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.
    Currie SM, Findlay EG, McHugh BJ, Mackellar A, Man T, Macmillan D, Wang H, Fitch PM, Schwarze J, Davidson DJ.
    PLoS One; 2013 Jul 14; 8(8):e73659. PubMed ID: 24023689
    [Abstract] [Full Text] [Related]

  • 15. Natural Binary Herbal Small Molecules Self-Assembled Nanogel for Synergistic Inhibition of Respiratory Syncytial Virus.
    Song D, Lu C, Chang C, Ji J, Lin L, Liu Y, Li H, Chen L, Chen Z, Chen R.
    ACS Biomater Sci Eng; 2024 Oct 14; 10(10):6648-6660. PubMed ID: 39324477
    [Abstract] [Full Text] [Related]

  • 16. Targeting Intracellular Ion Homeostasis for the Control of Respiratory Syncytial Virus.
    Norris MJ, Malhi M, Duan W, Ouyang H, Granados A, Cen Y, Tseng YC, Gubbay J, Maynes J, Moraes TJ.
    Am J Respir Cell Mol Biol; 2018 Dec 14; 59(6):733-744. PubMed ID: 30095982
    [Abstract] [Full Text] [Related]

  • 17. Discovery of novel benzothienoazepine derivatives as potent inhibitors of respiratory syncytial virus.
    Fordyce EAF, Brookes DW, Lise-Ciana C, Coates MS, Hunt SF, Ito K, King-Underwood J, Onions ST, Parra GF, Rapeport G, Sherbukhin V, Stockwell JA, Strong P, Thomas JC, Murray J.
    Bioorg Med Chem Lett; 2017 May 15; 27(10):2201-2206. PubMed ID: 28372911
    [Abstract] [Full Text] [Related]

  • 18. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
    Coates M, Brookes D, Kim YI, Allen H, Fordyce EAF, Meals EA, Colley T, Ciana CL, Parra GF, Sherbukhin V, Stockwell JA, Thomas JC, Hunt SF, Anderson-Dring L, Onions ST, Cass L, Murray PJ, Ito K, Strong P, DeVincenzo JP, Rapeport G.
    Antimicrob Agents Chemother; 2017 Sep 15; 61(9):. PubMed ID: 28652242
    [Abstract] [Full Text] [Related]

  • 19. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
    Broadbent L, Parke HG, Ferguson LJ, Millar A, Shields MD, Detalle L, Power UF.
    Antimicrob Agents Chemother; 2020 Jan 27; 64(2):. PubMed ID: 31767728
    [Abstract] [Full Text] [Related]

  • 20. Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.
    Xue M, Wang R, Harder O, Chen P, Lu M, Cai H, Li A, Liang X, Jennings R, La Perle K, Niewiesk S, Peeples ME, Li J.
    J Virol; 2020 Nov 23; 94(24):. PubMed ID: 32999025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.